Literature DB >> 17472508

Quality of life in patients with brain metastases treated with a palliative course of whole-brain radiotherapy.

Megan Doyle1, Nicole Marie Eve Bradley, Kathy Li, Emily Sinclair, Kelvin Lam, Grace Chan, Edward Chow, Elizabeth A Barnes, Cyril Danjoux, May N Tsao.   

Abstract

BACKGROUND: The primary objective of this study was to assess whether there was an improvement in quality of life for patients with brain metastases as measured 1 and 2 months after a course of whole-brain radiotherapy. The secondary objective was to assess the level of agreement between patient and proxy quality of life scores. METHODS AND MATERIALS: Sixty patients with brain metastases and their proxy completed the Functional Assessment of Cancer Therapy-Brain (FACT-BR) questionnaire independently. Proxies were given instructions to answer from the patient's perspective. Quality-of-life assessments were conducted at baseline, 1 month, and 2 months after completion of whole-brain radiotherapy. Paired t tests with Bonferroni adjustment for multiple comparisons were calculated to detect significant differences in global quality-of-life scores. Lin's concordance correlation coefficient measured agreement between patient and proxy quality-of-life ratings.
RESULTS: No significant difference was detected in overall quality of life after whole-brain radiotherapy. At 2 months after whole-brain radiotherapy, there was a trend toward worsening general and brain specific quality-of-life scores. There was poor concordance between patients and their proxies for all quality-of-life domains at baseline.
CONCLUSION: At 2 months after whole-brain radiotherapy, there was a trend toward worsening general and brain specific quality-of-life scores. Proxy rating of patients' quality of life showed poor concordance at baseline.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17472508     DOI: 10.1089/jpm.2006.0202

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  12 in total

1.  The Brain Symptom and Impact Questionnaire in brain metastases patients: a prospective long-term follow-up study.

Authors:  Natalie Pulenzas; Saurabh Ray; Liying Zhang; Rachel McDonald; David Cella; Leigha Rowbottom; Arjun Sahgal; Hany Soliman; May Tsao; Cyril Danjoux; Breanne Lechner; Edward Chow
Journal:  CNS Oncol       Date:  2015-12-18

Review 2.  Systematic review of caregiver responses for patient health-related quality of life in adult cancer care.

Authors:  Jessica K Roydhouse; Ira B Wilson
Journal:  Qual Life Res       Date:  2017-03-14       Impact factor: 4.147

3.  Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity.

Authors:  Meera Agar; Eng-Siew Koh; Emma Gibbs; Elizabeth H Barnes; Elizabeth Hovey; Ann Livingstone; Kate Sawkins; Richard Chye; Melanie R Lovell; Katherine Clark; Janette Vardy; Madeleine King
Journal:  Support Care Cancer       Date:  2015-08-21       Impact factor: 3.603

4.  Psychometric validation of the Brain Symptom and Impact Questionnaire (BASIQ) version 1.0 to assess quality of life in patients with brain metastases.

Authors:  Nemica Thavarajah; Saurabh Ray; Gillian Bedard; Liying Zhang; David Cella; Erin Wong; Cyril Danjoux; May Tsao; Elizabeth Barnes; Arjun Sahgal; Hany Soliman; Natalie Pulenzas; Breanne Lechner; Edward Chow
Journal:  CNS Oncol       Date:  2015

5.  Proxy assessment of patients before and after radiotherapy for brain metastases. Results of a prospective study using the DEGRO brain module.

Authors:  D Steinmann; D Vordermark; H Geinitz; R Aschoff; A Bayerl; J Gerstein; M Hipp; B van Oorschot; H J Wypior; C Schäfer
Journal:  Strahlenther Onkol       Date:  2012-11-18       Impact factor: 3.621

6.  Beyond palliative radiotherapy: a pilot multidisciplinary brain metastases clinic.

Authors:  Brita Danielson; Alysa Fairchild
Journal:  Support Care Cancer       Date:  2011-04-09       Impact factor: 3.603

7.  Psychometric validation of the functional assessment of cancer therapy--brain (FACT-Br) for assessing quality of life in patients with brain metastases.

Authors:  Nemica Thavarajah; Gillian Bedard; Liying Zhang; David Cella; Jennifer L Beaumont; May Tsao; Elizabeth Barnes; Cyril Danjoux; Arjun Sahgal; Hany Soliman; Edward Chow
Journal:  Support Care Cancer       Date:  2013-11-28       Impact factor: 3.603

8.  Exploration of symptoms clusters within cancer patients with brain metastases using the Spitzer Quality of Life Index.

Authors:  Amanda Hird; Jennifer Wong; Liying Zhang; May Tsao; Elizabeth Barnes; Cyril Danjoux; Edward Chow
Journal:  Support Care Cancer       Date:  2009-05-31       Impact factor: 3.603

9.  Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party.

Authors:  Diana Steinmann; Christof Schäfer; Birgitt van Oorschot; Hans-Joachim Wypior; Frank Bruns; Tobias Bölling; Susanne Sehlen; Juliane Hagg; Anja Bayerl; Hans Geinitz; Matthias Hipp; Dirk Vordermark
Journal:  Strahlenther Onkol       Date:  2009-03       Impact factor: 3.621

10.  Reporting of "quality of life": a systematic review and quantitative analysis of research publications in palliative care journals.

Authors:  Senthil P Kumar
Journal:  Indian J Palliat Care       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.